Corporate Profile
Ikena Oncology® develops differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. Ikena aims to utilize their depth of institutional knowledge and breadth of tools to efficiently develop the right drug using the right modality for the right patient.
Company Presentation
Stock Quote
Nov 06, 2024 6:48 PM EST
Minimum 15 minutes delayed. Source:
Recent Press Releases
Recent & Upcoming Events
Apr 16, 2024 at 2:00 PM EDT
Mar 05, 2024 at 12:50 PM EST
Nov 29, 2023 at 11:00 AM EST